{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2021/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Stefano V. Gulla", "item": "https://www.patentleaderboard.com/2021/inventor/fl:st_ln:gulla-1"}]}

Home › 2021 › Pfizer › Stefano V. Gulla

Stefano V. Gulla — 2 Patents in 2021

BCBoston Medical Center: 1 patents #1 of 18Top 6%

Pfizer: 1 patents #97 of 325Top 30%

Medford, MA: #23 of 185 inventorsTop 15%

Massachusetts: #2,417 of 14,123 inventorsTop 20%

Overall (2021): #110,141 of 548,734Top 25%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11180561	Killer cell lectin-like receptor subfamily G member 1 (KLRG1) depleting antibodies	Kenneth Evan Thompson	2021-11-23
10906955	Recombinant ROBO2 proteins, compositions, methods and uses thereof	Stephen Berasi, Janet Elizabeth Buhlmann, Nathan Higginson-Scott, Michael Shamashkin, Matthew Russo +5 more	2021-02-02	$640,415,000

Stefano V. Gulla — 2 Patents in 2021

Issued Patents 2021

Patent Widget